RECURRENT VULVOVAGINAL CANDIDIASIS
Clinical trials for RECURRENT VULVOVAGINAL CANDIDIASIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT VULVOVAGINAL CANDIDIASIS trials appear
Sign up with your email to follow new studies for RECURRENT VULVOVAGINAL CANDIDIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could keep yeast infections away for nearly a year
Disease control CompletedThis study tested a new oral medication, oteseconazole, in 425 women who have frequent yeast infections (at least 3 in the past year). Participants first received standard treatment for their current infection, then took either oteseconazole or a placebo daily for 12 weeks. The g…
Matched conditions: RECURRENT VULVOVAGINAL CANDIDIASIS
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New yeast infection pill shows promise in major trial
Disease control CompletedThis study tested a new oral medication, oteseconazole, to prevent recurrent yeast infections in women who had at least three infections in the past year. 438 participants first received standard treatment for their current infection, then took either oteseconazole or a placebo f…
Matched conditions: RECURRENT VULVOVAGINAL CANDIDIASIS
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC